APO Research
Talk to an analyst

APO RESEARCH · REPORT

Levosulpiride

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Levosulpiride Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchLevosulpiride Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Levosulpiride Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Levosulpiride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levosulpiride Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Levosulpiride Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Levosulpiride market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Levosulpiride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Levosulpiride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Levosulpiride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Levosulpiride is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Suzhou Chenghe Pharmaceutical & Chemical, Harbin Gloria Pharmaceuticals, Vasoya Industries, New Donghai Pharmaceutical and Bona Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Levosulpiride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Levosulpiride, also provides the sales of main regions and countries. Of the upcoming market potential for Levosulpiride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Levosulpiride sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Levosulpiride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Levosulpiride sales, projected growth trends, production technology, application and end-user industry.

Levosulpiride Segment by Company

Sun Pharmaceutical Industries

Suzhou Chenghe Pharmaceutical & Chemical

Harbin Gloria Pharmaceuticals

Vasoya Industries

New Donghai Pharmaceutical

Bona Chemical

Levosulpiride Segment by Type

Above 98%

Below 98%

Levosulpiride Segment by Application

Tablet

Capsule

Other

Levosulpiride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levosulpiride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levosulpiride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levosulpiride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Levosulpiride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levosulpiride sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Levosulpiride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Above 98% Major Manufacturers Table 3. Below 98% Major Manufacturers Table 4. Global Levosulpiride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tablet Major Manufacturers Table 6. Capsule Major Manufacturers Table 7. Other Major Manufacturers Table 8. Levosulpiride Industry Trends Table 9. Levosulpiride Industry Drivers Table 10. Levosulpiride Industry Opportunities and Challenges Table 11. Levosulpiride Industry Restraints Table 12. Global Levosulpiride Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Levosulpiride Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Levosulpiride Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Levosulpiride Revenue Market Share by Region (2021-2026) Table 16. Global Levosulpiride Revenue Market Share by Region (2027-2032) Table 17. Global Levosulpiride Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 18. Global Levosulpiride Sales by Region (2021-2026) & (kg) Table 19. Global Levosulpiride Sales by Region (2027-2032) & (kg) Table 20. Global Levosulpiride Sales Market Share by Region (2021-2026) Table 21. Global Levosulpiride Sales Market Share by Region (2027-2032) Table 22. Global Levosulpiride Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Levosulpiride Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Levosulpiride Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Levosulpiride Sales Market Share by Manufacturers (2021-2026) Table 26. Global Levosulpiride Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Levosulpiride Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Levosulpiride Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Levosulpiride Manufacturers, Product Type & Application Table 30. Global Levosulpiride Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Levosulpiride by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Levosulpiride Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Levosulpiride Revenue Market Share by Type (2021-2026) Table 37. Global Levosulpiride Revenue Market Share by Type (2027-2032) Table 38. Global Levosulpiride Sales by Type 2021 VS 2025 VS 2032 (kg) Table 39. Global Levosulpiride Sales by Type (2021-2026) & (kg) Table 40. Global Levosulpiride Sales by Type (2027-2032) & (kg) Table 41. Global Levosulpiride Sales Market Share by Type (2021-2026) Table 42. Global Levosulpiride Sales Market Share by Type (2027-2032) Table 43. Global Levosulpiride Price by Type (2021-2026) & (US$/kg) Table 44. Global Levosulpiride Price by Type (2027-2032) & (US$/kg) Table 45. Global Levosulpiride Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Levosulpiride Revenue Market Share by Application (2021-2026) Table 49. Global Levosulpiride Revenue Market Share by Application (2027-2032) Table 50. Global Levosulpiride Sales by Application 2021 VS 2025 VS 2032 (kg) Table 51. Global Levosulpiride Sales by Application (2021-2026) & (kg) Table 52. Global Levosulpiride Sales by Application (2027-2032) & (kg) Table 53. Global Levosulpiride Sales Market Share by Application (2021-2026) Table 54. Global Levosulpiride Sales Market Share by Application (2027-2032) Table 55. Global Levosulpiride Price by Application (2021-2026) & (US$/kg) Table 56. Global Levosulpiride Price by Application (2027-2032) & (US$/kg) Table 57. Sun Pharmaceutical Industries Company Information Table 58. Sun Pharmaceutical Industries Business Overview Table 59. Sun Pharmaceutical Industries Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. Sun Pharmaceutical Industries Levosulpiride Product Portfolio Table 61. Sun Pharmaceutical Industries Recent Development Table 62. Suzhou Chenghe Pharmaceutical & Chemical Company Information Table 63. Suzhou Chenghe Pharmaceutical & Chemical Business Overview Table 64. Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio Table 66. Suzhou Chenghe Pharmaceutical & Chemical Recent Development Table 67. Harbin Gloria Pharmaceuticals Company Information Table 68. Harbin Gloria Pharmaceuticals Business Overview Table 69. Harbin Gloria Pharmaceuticals Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio Table 71. Harbin Gloria Pharmaceuticals Recent Development Table 72. Vasoya Industries Company Information Table 73. Vasoya Industries Business Overview Table 74. Vasoya Industries Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Vasoya Industries Levosulpiride Product Portfolio Table 76. Vasoya Industries Recent Development Table 77. New Donghai Pharmaceutical Company Information Table 78. New Donghai Pharmaceutical Business Overview Table 79. New Donghai Pharmaceutical Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. New Donghai Pharmaceutical Levosulpiride Product Portfolio Table 81. New Donghai Pharmaceutical Recent Development Table 82. Bona Chemical Company Information Table 83. Bona Chemical Business Overview Table 84. Bona Chemical Levosulpiride Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Bona Chemical Levosulpiride Product Portfolio Table 86. Bona Chemical Recent Development Table 87. North America Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Levosulpiride Sales by Type (2021-2026) & (kg) Table 90. North America Levosulpiride Sales by Type (2027-2032) & (kg) Table 91. North America Levosulpiride Sales Price by Type (2021-2026) & (US$/kg) Table 92. North America Levosulpiride Sales Price by Type (2027-2032) & (US$/kg) Table 93. North America Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Levosulpiride Sales by Application (2021-2026) & (kg) Table 96. North America Levosulpiride Sales by Application (2027-2032) & (kg) Table 97. North America Levosulpiride Sales Price by Application (2021-2026) & (US$/kg) Table 98. North America Levosulpiride Sales Price by Application (2027-2032) & (US$/kg) Table 99. North America Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Levosulpiride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Levosulpiride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Levosulpiride Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 103. North America Levosulpiride Sales by Country (2021-2026) & (kg) Table 104. North America Levosulpiride Sales by Country (2027-2032) & (kg) Table 105. North America Levosulpiride Sales Price by Country (2021-2026) & (US$/kg) Table 106. North America Levosulpiride Sales Price by Country (2027-2032) & (US$/kg) Table 107. United States Levosulpiride Revenue (2021-2032) & (US$ Million) Table 108. Canada Levosulpiride Revenue (2021-2032) & (US$ Million) Table 109. Mexico Levosulpiride Revenue (2021-2032) & (US$ Million) Table 110. Europe Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Levosulpiride Sales by Type (2021-2026) & (kg) Table 113. Europe Levosulpiride Sales by Type (2027-2032) & (kg) Table 114. Europe Levosulpiride Sales Price by Type (2021-2026) & (US$/kg) Table 115. Europe Levosulpiride Sales Price by Type (2027-2032) & (US$/kg) Table 116. Europe Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Levosulpiride Sales by Application (2021-2026) & (kg) Table 119. Europe Levosulpiride Sales by Application (2027-2032) & (kg) Table 120. Europe Levosulpiride Sales Price by Application (2021-2026) & (US$/kg) Table 121. Europe Levosulpiride Sales Price by Application (2027-2032) & (US$/kg) Table 122. Europe Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Levosulpiride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Levosulpiride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Levosulpiride Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 126. Europe Levosulpiride Sales by Country (2021-2026) & (kg) Table 127. Europe Levosulpiride Sales by Country (2027-2032) & (kg) Table 128. Europe Levosulpiride Sales Price by Country (2021-2026) & (US$/kg) Table 129. Europe Levosulpiride Sales Price by Country (2027-2032) & (US$/kg) Table 130. Germany Levosulpiride Revenue (2021-2032) & (US$ Million) Table 131. France Levosulpiride Revenue (2021-2032) & (US$ Million) Table 132. U.K. Levosulpiride Revenue (2021-2032) & (US$ Million) Table 133. Italy Levosulpiride Revenue (2021-2032) & (US$ Million) Table 134. Russia Levosulpiride Revenue (2021-2032) & (US$ Million) Table 135. Spain Levosulpiride Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Levosulpiride Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Levosulpiride Revenue (2021-2032) & (US$ Million) Table 138. Sweden Levosulpiride Revenue (2021-2032) & (US$ Million) Table 139. Poland Levosulpiride Revenue (2021-2032) & (US$ Million) Table 140. China Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 141. China Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 142. China Levosulpiride Sales by Type (2021-2026) & (kg) Table 143. China Levosulpiride Sales by Type (2027-2032) & (kg) Table 144. China Levosulpiride Sales Price by Type (2021-2026) & (US$/kg) Table 145. China Levosulpiride Sales Price by Type (2027-2032) & (US$/kg) Table 146. China Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 147. China Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 148. China Levosulpiride Sales by Application (2021-2026) & (kg) Table 149. China Levosulpiride Sales by Application (2027-2032) & (kg) Table 150. China Levosulpiride Sales Price by Application (2021-2026) & (US$/kg) Table 151. China Levosulpiride Sales Price by Application (2027-2032) & (US$/kg) Table 152. Asia Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Levosulpiride Sales by Type (2021-2026) & (kg) Table 155. Asia Levosulpiride Sales by Type (2027-2032) & (kg) Table 156. Asia Levosulpiride Sales Price by Type (2021-2026) & (US$/kg) Table 157. Asia Levosulpiride Sales Price by Type (2027-2032) & (US$/kg) Table 158. Asia Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Levosulpiride Sales by Application (2021-2026) & (kg) Table 161. Asia Levosulpiride Sales by Application (2027-2032) & (kg) Table 162. Asia Levosulpiride Sales Price by Application (2021-2026) & (US$/kg) Table 163. Asia Levosulpiride Sales Price by Application (2027-2032) & (US$/kg) Table 164. Asia Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Levosulpiride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Levosulpiride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Levosulpiride Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 168. Asia Levosulpiride Sales by Country (2021-2026) & (kg) Table 169. Asia Levosulpiride Sales by Country (2027-2032) & (kg) Table 170. Asia Levosulpiride Sales Price by Country (2021-2026) & (US$/kg) Table 171. Asia Levosulpiride Sales Price by Country (2027-2032) & (US$/kg) Table 172. Japan Levosulpiride Revenue (2021-2032) & (US$ Million) Table 173. South Korea Levosulpiride Revenue (2021-2032) & (US$ Million) Table 174. India Levosulpiride Revenue (2021-2032) & (US$ Million) Table 175. Australia Levosulpiride Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Levosulpiride Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Levosulpiride Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Levosulpiride Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Levosulpiride Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Levosulpiride Sales by Type (2021-2026) & (kg) Table 181. SAMEA Levosulpiride Sales by Type (2027-2032) & (kg) Table 182. SAMEA Levosulpiride Sales Price by Type (2021-2026) & (US$/kg) Table 183. SAMEA Levosulpiride Sales Price by Type (2027-2032) & (US$/kg) Table 184. SAMEA Levosulpiride Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Levosulpiride Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Levosulpiride Sales by Application (2021-2026) & (kg) Table 187. SAMEA Levosulpiride Sales by Application (2027-2032) & (kg) Table 188. SAMEA Levosulpiride Sales Price by Application (2021-2026) & (US$/kg) Table 189. SAMEA Levosulpiride Sales Price by Application (2027-2032) & (US$/kg) Table 190. SAMEA Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Levosulpiride Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Levosulpiride Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Levosulpiride Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 194. SAMEA Levosulpiride Sales by Country (2021-2026) & (kg) Table 195. SAMEA Levosulpiride Sales by Country (2027-2032) & (kg) Table 196. SAMEA Levosulpiride Sales Price by Country (2021-2026) & (US$/kg) Table 197. SAMEA Levosulpiride Sales Price by Country (2027-2032) & (US$/kg) Table 198. Brazil Levosulpiride Revenue (2021-2032) & (US$ Million) Table 199. Argentina Levosulpiride Revenue (2021-2032) & (US$ Million) Table 200. Chile Levosulpiride Revenue (2021-2032) & (US$ Million) Table 201. Colombia Levosulpiride Revenue (2021-2032) & (US$ Million) Table 202. Peru Levosulpiride Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Levosulpiride Revenue (2021-2032) & (US$ Million) Table 204. Israel Levosulpiride Revenue (2021-2032) & (US$ Million) Table 205. UAE Levosulpiride Revenue (2021-2032) & (US$ Million) Table 206. Turkey Levosulpiride Revenue (2021-2032) & (US$ Million) Table 207. Iran Levosulpiride Revenue (2021-2032) & (US$ Million) Table 208. Egypt Levosulpiride Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Levosulpiride Distributors List Table 212. Levosulpiride Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Levosulpiride Image Figure 2. Global Levosulpiride Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levosulpiride Market Size Share 2021 VS 2025 VS 2032 Figure 4. Above 98% Image Figure 5. Below 98% Image Figure 6. Global Levosulpiride Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Levosulpiride Market Size Share 2021 VS 2025 VS 2032 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Other Image Figure 11. Global Levosulpiride Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Levosulpiride Revenue (2021-2032) & (US$ Million) Figure 13. Global Levosulpiride Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Levosulpiride Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Levosulpiride Revenue Market Share by Region (2021-2032) Figure 16. Global Levosulpiride Sales (2021-2032) & (kg) Figure 17. Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 18. Global Levosulpiride Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Levosulpiride Sales YoY (2021-2032) & (kg) Figure 20. Europe Levosulpiride Sales YoY (2021-2032) & (kg) Figure 21. China Levosulpiride Sales YoY (2021-2032) & (kg) Figure 22. Asia (Excluding China) Levosulpiride Sales YoY (2021-2032) & (kg) Figure 23. South America, Middle East and Africa Levosulpiride Sales YoY (2021-2032) & (kg) Figure 24. Global Levosulpiride Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Levosulpiride Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Levosulpiride Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Levosulpiride Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Levosulpiride Revenue Market Share by Type (2021-2032) Figure 30. Global Levosulpiride Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 31. Global Levosulpiride Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Levosulpiride Sales Market Share by Type (2021-2032) Figure 33. Global Levosulpiride Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Levosulpiride Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Levosulpiride Revenue Market Share by Application (2021-2032) Figure 36. Global Levosulpiride Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 37. Global Levosulpiride Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Levosulpiride Sales Market Share by Application (2021-2032) Figure 39. North America Levosulpiride Revenue Share by Type (2021-2032) Figure 40. North America Levosulpiride Sales Share by Type (2021-2032) Figure 41. North America Levosulpiride Revenue Share by Application (2021-2032) Figure 42. North America Levosulpiride Sales Share by Application (2021-2032) Figure 43. North America Levosulpiride Revenue Share by Country (2021-2032) Figure 44. North America Levosulpiride Sales Share by Country (2021-2032) Figure 45. Europe Levosulpiride Revenue Share by Type (2021-2032) Figure 46. Europe Levosulpiride Sales Share by Type (2021-2032) Figure 47. Europe Levosulpiride Revenue Share by Application (2021-2032) Figure 48. Europe Levosulpiride Sales Share by Application (2021-2032) Figure 49. Europe Levosulpiride Revenue Share by Country (2021-2032) Figure 50. Europe Levosulpiride Sales Share by Country (2021-2032) Figure 51. China Levosulpiride Revenue Share by Type (2021-2032) Figure 52. China Levosulpiride Sales Share by Type (2021-2032) Figure 53. China Levosulpiride Revenue Share by Application (2021-2032) Figure 54. China Levosulpiride Sales Share by Application (2021-2032) Figure 55. Asia Levosulpiride Revenue Share by Type (2021-2032) Figure 56. Asia Levosulpiride Sales Share by Type (2021-2032) Figure 57. Asia Levosulpiride Revenue Share by Application (2021-2032) Figure 58. Asia Levosulpiride Sales Share by Application (2021-2032) Figure 59. Asia Levosulpiride Revenue Share by Country (2021-2032) Figure 60. Asia Levosulpiride Sales Share by Country (2021-2032) Figure 61. SAMEA Levosulpiride Revenue Share by Type (2021-2032) Figure 62. SAMEA Levosulpiride Sales Share by Type (2021-2032) Figure 63. SAMEA Levosulpiride Revenue Share by Application (2021-2032) Figure 64. SAMEA Levosulpiride Sales Share by Application (2021-2032) Figure 65. SAMEA Levosulpiride Revenue Share by Country (2021-2032) Figure 66. SAMEA Levosulpiride Sales Share by Country (2021-2032) Figure 67. Levosulpiride Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Levosulpiride Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Above 98%
  • Below 98%
Applications
  • Tablet
  • Capsule
  • Other
Companies covered
  • Sun Pharmaceutical Industries
  • Suzhou Chenghe Pharmaceutical & Chemical
  • Harbin Gloria Pharmaceuticals
  • Vasoya Industries
  • New Donghai Pharmaceutical
  • Bona Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Levosulpiride Market by Type
  3. 1.2.1 Global Levosulpiride Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Above 98%
  5. 1.2.3 Below 98%
  6. 1.3 Levosulpiride Market by Application
  7. 1.3.1 Global Levosulpiride Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tablet
  9. 1.3.3 Capsule
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Levosulpiride Market Dynamics
  1. 2.1 Levosulpiride Industry Trends
  2. 2.2 Levosulpiride Industry Drivers
  3. 2.3 Levosulpiride Industry Opportunities and Challenges
  4. 2.4 Levosulpiride Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Levosulpiride Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Levosulpiride Revenue by Region
  3. 3.2.1 Global Levosulpiride Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Levosulpiride Revenue by Region (2021-2026)
  5. 3.2.3 Global Levosulpiride Revenue by Region (2027-2032)
  6. 3.2.4 Global Levosulpiride Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Levosulpiride Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Levosulpiride Sales by Region
  9. 3.4.1 Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Levosulpiride Sales by Region (2021-2026)
  11. 3.4.3 Global Levosulpiride Sales by Region (2027-2032)
  12. 3.4.4 Global Levosulpiride Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Levosulpiride Revenue by Manufacturers
  2. 4.1.1 Global Levosulpiride Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Levosulpiride Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Levosulpiride Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Levosulpiride Sales by Manufacturers
  6. 4.2.1 Global Levosulpiride Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Levosulpiride Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Levosulpiride Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Levosulpiride Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Levosulpiride Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Levosulpiride Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Levosulpiride Manufacturers, Product Type & Application
  13. 4.7 Global Levosulpiride Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Levosulpiride Market CR5 and HHI
  16. 4.8.2 2025 Levosulpiride Tier 1, Tier 2, and Tier 3
5 Levosulpiride Market by Type
  1. 5.1 Global Levosulpiride Revenue by Type
  2. 5.1.1 Global Levosulpiride Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Levosulpiride Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Levosulpiride Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Levosulpiride Sales by Type
  6. 5.2.1 Global Levosulpiride Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Levosulpiride Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Levosulpiride Sales Market Share by Type (2021-2032)
  9. 5.3 Global Levosulpiride Price by Type
6 Levosulpiride Market by Application
  1. 6.1 Global Levosulpiride Revenue by Application
  2. 6.1.1 Global Levosulpiride Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Levosulpiride Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Levosulpiride Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Levosulpiride Sales by Application
  6. 6.2.1 Global Levosulpiride Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Levosulpiride Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Levosulpiride Sales Market Share by Application (2021-2032)
  9. 6.3 Global Levosulpiride Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical Industries
  2. 7.1.1 Sun Pharmaceutical Industries Company Information
  3. 7.1.2 Sun Pharmaceutical Industries Business Overview
  4. 7.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 7.2 Suzhou Chenghe Pharmaceutical & Chemical
  8. 7.2.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
  9. 7.2.2 Suzhou Chenghe Pharmaceutical & Chemical Business Overview
  10. 7.2.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
  12. 7.2.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments
  13. 7.3 Harbin Gloria Pharmaceuticals
  14. 7.3.1 Harbin Gloria Pharmaceuticals Company Information
  15. 7.3.2 Harbin Gloria Pharmaceuticals Business Overview
  16. 7.3.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
  18. 7.3.5 Harbin Gloria Pharmaceuticals Recent Developments
  19. 7.4 Vasoya Industries
  20. 7.4.1 Vasoya Industries Company Information
  21. 7.4.2 Vasoya Industries Business Overview
  22. 7.4.3 Vasoya Industries Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vasoya Industries Levosulpiride Product Portfolio
  24. 7.4.5 Vasoya Industries Recent Developments
  25. 7.5 New Donghai Pharmaceutical
  26. 7.5.1 New Donghai Pharmaceutical Company Information
  27. 7.5.2 New Donghai Pharmaceutical Business Overview
  28. 7.5.3 New Donghai Pharmaceutical Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
  30. 7.5.5 New Donghai Pharmaceutical Recent Developments
  31. 7.6 Bona Chemical
  32. 7.6.1 Bona Chemical Company Information
  33. 7.6.2 Bona Chemical Business Overview
  34. 7.6.3 Bona Chemical Levosulpiride Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bona Chemical Levosulpiride Product Portfolio
  36. 7.6.5 Bona Chemical Recent Developments
8 North America
  1. 8.1 North America Levosulpiride Market Size by Type
  2. 8.1.1 North America Levosulpiride Revenue by Type (2021-2032)
  3. 8.1.2 North America Levosulpiride Sales by Type (2021-2032)
  4. 8.1.3 North America Levosulpiride Price by Type (2021-2032)
  5. 8.2 North America Levosulpiride Market Size by Application
  6. 8.2.1 North America Levosulpiride Revenue by Application (2021-2032)
  7. 8.2.2 North America Levosulpiride Sales by Application (2021-2032)
  8. 8.2.3 North America Levosulpiride Price by Application (2021-2032)
  9. 8.3 North America Levosulpiride Market Size by Country
  10. 8.3.1 North America Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Levosulpiride Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Levosulpiride Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Levosulpiride Market Size by Type
  2. 9.1.1 Europe Levosulpiride Revenue by Type (2021-2032)
  3. 9.1.2 Europe Levosulpiride Sales by Type (2021-2032)
  4. 9.1.3 Europe Levosulpiride Price by Type (2021-2032)
  5. 9.2 Europe Levosulpiride Market Size by Application
  6. 9.2.1 Europe Levosulpiride Revenue by Application (2021-2032)
  7. 9.2.2 Europe Levosulpiride Sales by Application (2021-2032)
  8. 9.2.3 Europe Levosulpiride Price by Application (2021-2032)
  9. 9.3 Europe Levosulpiride Market Size by Country
  10. 9.3.1 Europe Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Levosulpiride Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Levosulpiride Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Levosulpiride Market Size by Type
  2. 10.1.1 China Levosulpiride Revenue by Type (2021-2032)
  3. 10.1.2 China Levosulpiride Sales by Type (2021-2032)
  4. 10.1.3 China Levosulpiride Price by Type (2021-2032)
  5. 10.2 China Levosulpiride Market Size by Application
  6. 10.2.1 China Levosulpiride Revenue by Application (2021-2032)
  7. 10.2.2 China Levosulpiride Sales by Application (2021-2032)
  8. 10.2.3 China Levosulpiride Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Levosulpiride Market Size by Type
  2. 11.1.1 Asia Levosulpiride Revenue by Type (2021-2032)
  3. 11.1.2 Asia Levosulpiride Sales by Type (2021-2032)
  4. 11.1.3 Asia Levosulpiride Price by Type (2021-2032)
  5. 11.2 Asia Levosulpiride Market Size by Application
  6. 11.2.1 Asia Levosulpiride Revenue by Application (2021-2032)
  7. 11.2.2 Asia Levosulpiride Sales by Application (2021-2032)
  8. 11.2.3 Asia Levosulpiride Price by Application (2021-2032)
  9. 11.3 Asia Levosulpiride Market Size by Country
  10. 11.3.1 Asia Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Levosulpiride Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Levosulpiride Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Levosulpiride Market Size by Type
  2. 12.1.1 SAMEA Levosulpiride Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Levosulpiride Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Levosulpiride Price by Type (2021-2032)
  5. 12.2 SAMEA Levosulpiride Market Size by Application
  6. 12.2.1 SAMEA Levosulpiride Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Levosulpiride Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Levosulpiride Price by Application (2021-2032)
  9. 12.3 SAMEA Levosulpiride Market Size by Country
  10. 12.3.1 SAMEA Levosulpiride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Levosulpiride Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Levosulpiride Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Levosulpiride Value Chain Analysis
  2. 13.1.1 Levosulpiride Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Levosulpiride Production Mode & Process
  6. 13.2 Levosulpiride Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Levosulpiride Distributors
  9. 13.2.3 Levosulpiride Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst